p21 activated kinases

5-Aminosalicylic Acid (5-ASA) is a specific PPARγ agonist and also inhibits P21-activated kinase 1(PAK1) and NF-Κb. 5-Aminosalicylic Acid has anti-cancer and anti-inflammatory activities. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

Mesalamine-d3 is a deuterated compound of Mesalamine. Mesalamine has a CAS number of 89-57-6. Mesalamine is an anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE.

5-Aminosalicylic acid-d3 is the deuterated form of 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) functions as a specific PPARγ agonist and also inhibits both p21-activated kinase 1 (PAK1) and NF-κB.

5-Aminosalicylic acid (Standard) is the standard substance of 5-Aminosalicylic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. 5-Aminosalicylic Acid (5-ASA) is a specific PPARγ agonist and also inhibits P21-activated kinase 1(PAK1) and NF-Κb. 5-Aminosalicylic Acid has anti-cancer and anti-inflammatory activities. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

5-Aminosalicylic acid-d3disodium is a deuterium-labeled variant of 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) functions as a specific PPARγ agonist, and it also inhibits p21-activated kinase 1 (PAK1) and NF-κB. Additionally, it acts to suppress the activity of osteopontin (OPN).

5-Aminosalicylic acid-13C6 is the 13C-labeled form of 5-Aminosalicylic Acid. This compound, also known as 5-Aminosalicylic acid (Mesalamine), acts as a specific agonist for PPARγ and inhibits p21-activated kinase 1 (PAK1) as well as NF-κB.